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Abstract
One of the most remarkable properties of interleukin 8 (CXCL8/IL-8), a chemokine with known additional functions also in
angiogenesis and tissue remodeling, is the variation of its expression levels. In healthy tissues, IL-8 is barely detectable, but it
is rapidly induced by several folds in response to proinflammatory cytokines, bacterial or viral products, and cellular stress.
Although mouse cells do not bear a clear homologous IL-8 gene, the murine transcriptional apparatus may well be capable
of activating or repressing a heterologous IL-8 gene promoter driving a reporter gene. In order to induce a transient
transgenic expression, mice were systemically injected with a bovine IL-8 promoter–luciferase construct. Subsequently mice
were monitored for luciferase expression in the lung by in vivo bioluminescent image analysis over an extended period of
time (up to 60 days). We demonstrate that the bovine IL-8 promoter–luciferase construct is transiently and robustly
activated 3–5 hours after LPS and TNF-a instillation into the lung, peaking at 35 days after construct delivery. Bovine IL-8
promoter–luciferase activation correlates with white blood cell and neutrophil infiltration into the lung. This study
demonstrates that a small experimental rodent model can be utilized for non-invasively monitoring, through a reporter
gene system, the activation of an IL-8 promoter region derived from a larger size animal (bovine). This proof of principle
study has the potential to be utilized also for studying primate IL-8 promoter regions.
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Introduction
Severe respiratory diseases in ruminants and human are character-
ized by pneumonia with extensive infiltration of polymorphonuclear
inflammatory cells (PMNs) in small airways and alveoli, by the
accumulation of fibrinous oedema in the alveoli, pleura surface and
interlobular septa, by hemorrhage, vascular thrombosis and coagula-
tive parenchymal necrosis of the lung [1,2].
Several bacteria and viruses overcoming host defense mecha-
nisms and proliferating in the lung are the main triggering factors
of lung inflammation and polymorphonuclear leukocytes (PMNs)
are directly and indirectly responsible for most of the lung
pathologies and lesions [2,3]. Mobilization of PMNs in the
inflamed lung is modulated by the interactions of leucocytes and
cytokines. During the acute-phase response of the pneumonic
process caused by infectious agents in ruminants and human, the
inflammatory cytokines such as IL-1b, TNF-a and IL-8, secreted
by a variety of immune and non immune cell types, induce a
strong PMNs mobilization and an increased inflammatory
response [2,3]. PMNs mobilization does not always effectively
combat the infection and may also contribute to the development
of lesions in the lung. During the development of lung
inflammation IL-1b and TNF-a are initially produced, thereby
inducing a strong IL-8 secretion, the most potent PMNs
chemotactic and activating factor. IL-1b, TNF-a and especially
IL-8, promote PMNs-mediated tissue injury by stimulating
degranulation of PMNs and extracellular release of arachidonic
acid metabolites, toxic oxygen radicals and proteolytic enzymes
[4]. Hence, IL-8 could be considered a downstream event that is
dependent, at least in part, on the prior secretion of early response
cytokines such as IL-1b and TNF-a [1,2,4] and this assumption
has very important implications for therapeutic strategies directed
toward the modulation of inflammatory cytokines. First of all
pharmacologic molecules inhibiting or antagonizing the biological
effect of inflammatory cytokines should be mainly directed toward
IL-8. Next, anti-cytokine drugs should be administrated very early
to prevent irreversible lung lesions [5,6].
Interleukin-8 (CXCL8/IL-8) is secreted by a variety of immune
and non immune cell types. The human chemokine IL-8 is an 8.5-
kDa C-X-C chemokine member of the CXC chemokine family,
which acts through the G protein-coupled receptors CXCR1 and
CXCR2. IL-8/CXCL8 complex is capable of activating the
expression of adhesion molecules in endothelial cells [7] and is an
important chemoattractant for neutrophils [8] as well as T-cells [9]
and monocytes [10]. In neutrophils, in particular, IL-8 induces
shape changes, exocytosis of stored proteins, and the respiratory
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peroxide. IL-8 is also involved in a wide variety of pathological
processes, including host defenses against bacterial infections,
angiogenesis and immune disorders [11]. One of the most
remarkable property of IL-8 is the rapid variation of its expression
levels in response to numerous stimuli. In healthy tissues, IL-8 is
barely detectable, but it is rapidly induced in response to pro-
inflammatory cytokines such as tumor necrosis factor alpha (TNF-
a) or IL-1, bacterial or viral products, and cellular stress.
Different signaling pathwayscoordinatelyregulate IL-8 transcription
as well as mRNA stabilization in response to external stimuli. Maximal
IL-8 amounts are generated by a combination of three different
mechanisms: first, derepression of the gene promoter; second,
transcriptional activation of the gene by nuclear factor-kappaB (NF-
kB) and JUN-N-terminal protein kinase (JNK) pathways; and third,
stabilization of the mRNA by the p38 mitogen-activated protein kinase
pathway. This complex regulation renders cells capable of rapidly
increasing and, at the same time, to fine-tuning the amount of IL-8
secreted, thereby tightly controlling the extent of leukocytes attracted to
t h es i t eo ft i s s u ei n j u r y .
Although post-transcriptional regulation of IL-8 expression has
been shown to be important, transcriptional regulation linked to
the activation of pro-inflammatory molecule receptors, such as
TLRs, IL-1 and TNF-a receptors, remains crucial in modulating
IL-8 expression [12]. Available data suggested that the NF-kB and
JNK pathways are indispensable for the transcriptional regulation
of IL-8 expression. Using the chromatin immune-precipitation
technique, Nissen and Yamamoto demonstrated the binding of
p65 NF-kB to the IL-8 promoter and the subsequent formation of
a TNF-a-stimulated pre-initiation complex containing inducible
phosphorilated RNA polymerase II [13,14]. Therefore, establish-
ing an in vivo molecular read-out to monitor IL-8 induction
following a specific inflammatory stimulus would be of great value
for testing new strategies directed toward the transcriptional
modulation of IL-8 production. Although the manifestation of
lung diseases in ruminants overlaps in most respect the manifes-
tation of lung diseases in human [2,3], the use of ruminants
(bovine, sheep or goat) as animal models is very costly and
demanding in terms of maintenance and the availability of
advanced genetic or immunologic resources is significantly limited
when compared with those available for rodent studies. On the
other hand, no clear-cut IL-8 homolog in rat or mouse has been
identified so far, although MIP-2 and KC may be functional
homologs of IL-8 in mice [15]. Furthermore, IL-8 binds to two
types of IL-8 receptors in humans, while mouse has only one
potential IL-8 receptor (homolog of human CXCR2). Although
mice lack an exact homolog of IL-8, the murine CXCR2 homolog
is activated by other neutrophils chemoattractants, namely MIP-2
and KC. Indeed, gene targeting of CXCR2 in mice exhibited
inhibition of neutrophil infiltration into inflamed tissue [16] and
mice transiently overexpressing IL-8 exhibit excessive accumula-
tion of neutrophils in the microcirculation of the lung, liver, and
spleen [15]. Based on the above information it was hypothesized
that, although mouse cells do not bear a clear homologous of IL-8
gene, murine transcriptional apparatus may nonetheless be
capable of activating or repressing a heterologous IL-8 gene
promoter driving a reporter gene. The possibility of monitoring in
small rodents in vivo luciferase reporter genes under the control of
cytokine promoters derived from other species would be of great
value for studying the pathophysiology of inflammatory responses
as well as to test interventions aimed at modulating such responses.
In the present study this hypothesis was successfully tested by
utilizing a molecular imaging approach based on a previously well
characterized bovine IL-8 promoter/luciferase reporter construct
[17] in mice. This study paves the way to non-invasive imaging
approaches for studying mechanisms and signaling pathways
underlying regulation of IL-8 expression.
Results
The Bovine IL-8 Promoter is Responsive in Mouse Lung
Cells in vitro
The bovine IL-8 promoter, mapped on Bos taurus chromosome
6 (http://www.ncbi.nlm.nih.gov/mapview/maps.cgitaxid=9913&
chr=6&query=uid(207248,3567299)&QSTR=280828%5Bgene%
5Fid%5D&maps=gene_set&cmd=focus), was previously cloned from
bovine genomic DNA template and its activation at the transcriptional
level tested with a luciferase reporter construct bIL-8-Luc. The
luciferase construct was generated by sub-cloning the 2030 bp IL-8
promoter in front of a pGL3 Luciferase reporter vector [17]. The
capability of mouse cells to trans-activate the bovine IL-8 promoter/
luciferase reporter construct (bIL-8-Luc, Fig. 1A) was first tested in an
in vitro model. The expression of Toll Like receptors (TLRs,) was
evaluated by RT-PCR in the LA-4 cell line, a mouse epithelial cell line
from lung, TLR 1, 2, 3, 4, 5, 6, 8 and 9 were detectable, while no
expression of TLR7 was identified (Fig. 1B). Secondly, TNF-a and
TNF-a receptor (TNF-aR) I and II were both found expressed in LA-
4c e l l s( Fig. 1C). Subsequently, LA-4 cells were transiently transfected
by electroporation with the bIL-8-luc reporter construct and 24 h post
transfection the cells were treated with TNF-a or LPS. In bIL-8-luc
transfected LA-4 cells, a 4 hour treatment with TNF-a increased
luciferase signal up to 3 folds, while, similarly, a 4 hour treatment with
LPS elicited a 2-fold induction (Fig. 1D). Signal intensity was
expressed as folds of induction over the bIL-8-luc transfected vehicle-
treated LA-4 cells. Results are reported as mean 6 SD and
significance attributed when P,0.05 (*) or P,0.01(**).
The Bovine IL-8 Promoter is Responsive in Mouse Lung in
vivo
Given the positive results obtained in vitro, bIL-8-luc reporter
construct was tested in vivo. Mice were first transiently transgenized
with bIL-8-luc or the Empty vector control (pGL3 basic) and 10 days
post transgenization were intratracheally instilled with LPS or TNF-
a. At different time points (3, 5 and 24 hours) post instillation mice
were monitored for luciferase expression in the lung by in vivo image
analysis. Mice responded to both treatments with a robust induction
already at 3 hours after instillation and the response still remained
significant after 24 hours. In contrast no signal was observed for
control mice treated with saline or transiently transgenized with the
Emptyvector(Fig. 2A and B). Signal intensity was then expressed as
folds of induction where the untreated control was considered as 1
(Fig. 2C). A further control was established with mice transiently
transgenized with different promoter reporter constructs such as
STAT-1-Luc and ELK-1-Luc and no signal was detected after LPS
or TNF-a treatment (Figure S1).
This in vivo analysis demonstrated the striking specificity of the
system and a better induction with a lower background compared
to the data obtained in vitro. Results are reported as mean 6 SD
and significance attributed when P,0.05 (*) or P,0.01(**).
Long Lasting Response of Bovine IL-8 Reporter Gene in
vivo
Similarly to in vitro transient transfections, the gene delivery
system employed in vivo is expected to result in a transient
expression of the delivered bIL-8-Luc reporter construct. It was
therefore important to assess the extent and the duration in vivo of
the responsiveness of the bIL-8-Luc reporter construct. Mice
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intratracheally instilled with LPS or TNF-a at 8, 32, 45 and 60
days post transgenization and 3, 5, or 24 h post treatment were
monitored for luciferase expression in the lung by in vivo image
analysis. Surprisingly, transiently transgenized mice responded to
LPS or TNF-a up to 60 days after transfection (Fig. 3) with the
greater response at 32 days. In contrast, no signal was detectable in
mice treated with saline or transiently transgenized with the
Empty vector. Results are reported as mean 6 SD and
significance attributed when P,0.05 (*) or P,0.01(**).
Thus, our data suggest that the same mice can be utilized or
reutilized for at least 45 days after the administration of the
reporter gene, saving animals and costs. This will offer the
opportunity of monitoring every single animal over an extended
time period.
Bovine IL-8 Reporter Gene Response Correlates with
White Blood Cells and Neutrophils Infiltration
Since IL-8 is a major chemotactic polypeptide for neutrophils,
we examined the correlation between bIL-8-Luc activation and
neutrophils infiltration into the lung upon LPS or TNF-a
stimulation. Ten days post bIL-8-Luc transient transgenization,
the mice were intratracheally instilled with LPS, TNF-a or saline
solution. Three hours post treatment, which was the time
Figure 1. In vitro characterization of bIL-8-Luc reporter construct. A) Schematic diagram (not to scale) of the Bos taurus chromosome 6 with
the IL-8 gene locus comprising promoter and exons annotated by numbers. The 2 kb IL-8 promoter sequence, comprising the putative TATA box, the
transcriptional start site (+1) and the UTR (red underlined) was cloned into the pGL3 basic vector in front of the open reading frame of the Luciferase
reporter. B) RT-PCR products of TLRs from 1 to 9 and their corresponding amplicon size. GAPDH was used as an internal control and the amplification
performed in the absence of reverse transcriptase (-RT) as a negative control. C) RT-PCR products of TNF-aRI,II and their corresponding amplicon size.
GAPDH was used as an internal control and the amplification performed in the absence of reverse transcriptase (-RT) as a negative control. D) IL-8
promoter activation after treatment of bIL-8-Luc transfected LA-4 cells with LPS or TNF-a, along with the untreated control (Untr.). Each experiment
was done in quadruplicate, and each point represents the mean 6 standard deviation of three experiments. Data were expressed as folds of
induction (2,1 and 2,8 for LPS and TNF-a respectively) over vehicle-treated cells and statistical differences were tested by One Way ANOVA followed
by Dunnet’s post hoc test for group comparisons. Results are reported as mean 6 SD and significance attributed when P,0.05 (*) or P,0.01(**).
doi:10.1371/journal.pone.0039716.g001
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post treatment, corresponding to the decline of the signal, the
lungs of the treated mice were intratracheally washed and the
broncho-alveolar lavage fluid (BALF) was assayed for the presence
of infiltrating total white blood cells (WBC) and neutrophils. As
shown in Fig. 4, WBC and neutrophils significantly increased in
treated mice with respect to the untreated control, whereas the
number of monocytes remained constant, a finding in line with the
notion that monocytic infiltration is typically a late event of
inflammatory responses. However, in terms of cellular infiltration
response, LPS gave a better response than TNF-a. Thus a positive
correlation between bIL-8-Luc reporter construct activation and
white blood cells and neutrophils infiltration was observed. Results
are reported as mean 6 SD and significance attributed when
P,0.05 (*) or P,0.01(**).
Discussion
A hallmark of tissue inflammation following chemical, physical
or microbiological insults is the recruitment of white blood cells to
the injured tissue, which is orchestrated by chemotactic polypep-
tides named chemokines, among which IL-8 is one of the most
remarkable. A significant correlation between IL-8 levels and
neutrophil infiltration in diseases has been reported. IL-8 is an
essential factor for acute inflammation and induces the infiltration
of T lymphocytes into inflamed tissue. Recent studies have also
demonstrated that IL-8 is involved in non-inflammatory reactions
like angiogenesis [18]. In addition, systemic administration of IL-
8 rapidly induces migration of hematopoietic stem cells from
bone marrow to peripheral blood [19]. These results suggest that
IL-8 also regulates non-inflammatory physiological reactions in
vivo.
L-8 transcriptional activation is closely correlated with the
initiation of acute inflammatory responses and thus is an ideal
indirect read-out for monitoring the activation of inflammatory
pathways targeting IL-8 expression. IL-8 homologs in many
species have been cloned, including human [12], macaque [20],
Sooty mangabey [21], bovine [22], sheep [23], pig [24], dog
[25], rabbit [26], Guinea pig [27] and chicken [28]; however, a
homolog of IL-8 has not been described in small rodents,
including mice. In this study we developed a useful murine
model for monitoring IL-8 expression in vivo. To this aim the
bovine IL-8 promoter was chosen for two main reasons. First,
lung inflammation-associated diseases in ruminants are very
important in terms of economic loss for the beef meat industry;
according to a report of the Committee for Animal Health
Research Programs, major disease-related losses attributed to
respiratory infections were calculated to be ,400 million Euros
per year; therefore the creation of an innovative in vivo platform
for testing new respiratory anti-inflammatory drugs targeting
specific pathways, such as IL-8, would be highly desirable.
Second, all the information obtained on IL-8 bovinized mice
can be easily employed for the human lung inflammation
associated diseases, due to the high similarity existing between
respiratory diseases in ruminants and human.
Although the minimal responsive sequence for the bovine IL-8
promoter is represented by the first 200 bp starting from the
putative transcriptional initiation site, a 2 kb large version of the
promoter was utilized [17] in order to include most of the
potentially relevant binding sites for transcription factors. More-
over, recently two IL-8 promoter haplotypes have been charac-
terized: the type 1, less sensitive to LPS and TNF-a and the type 2
with higher sensitivity to LPS and TNF-a [29].
Because IL-8 was previously shown to be expressed by a human
epithelial cell line derived from lung after specific stimuli [30,31],
the bIL-8 reporter construct was initially tested in vitro in a mouse
lung epithelial cell line, LA-4, which expresses TLRs and TNF-
aRs. Although mice and rats do not have IL-8 gene, bovine IL-8
promoter/luciferase reporter construct was expressed at detectable
levels in transfected LA-4 cells and was significantly induced upon
treatment with LPS or TNF-a. This simple but extremely
informative experiment demonstrates that mouse cells have the
transcriptional machinery for transactivating a heterologous IL-8
promoter/luciferase reporter construct.
To functionally test the IL-8 promoter/luciferase reporter
construct in mice, an in vivo bioluminescent imaging (BLI) approach
was exploited. BLI is a sensitive tool that is based on the detection of
light emission from cells or tissues [32]. The utility of reporter gene
technology makes it possible to analyze specific cellular and
biological processes in a living animal through in vivo imaging
methods. Bioluminescence from luciferase gene expression, as is the
case of the reporter construct employed during this study, is the
most widely used. Because mammalian tissues do not naturally emit
bioluminescence, in vivo BLI has considerable appeal because images
can be generated with absence of background signal. BLI requires
an expression cassette consisting of the bioluminescence reporter
gene (in this case was luciferase) under the control of a selected
promoter (in this experimental setting a bovine IL-8 gene promoter)
driving the reporter. In order to induce light production, the
substrate luciferin must be provided by intravascular or intraper-
itoneal injection. To date, there have been no reports of toxicity
related to repeated dosing of substrates [32].
Although delivery of cationic polyethylenimine (PEI)/DNA
complex could cause mortality when injected in mice in a strain
dependent manner, we observed 100% survival rate when bIL-8-
luc DNA was intravenously injected in FVB mice. Furthermore, a
more robust fold-induction in response to LPS or TNF-a was
obtained in the lung of bIL-8-luc DNA injected mice than in bIL-
8-luc DNA transfected LA-4 cells. Indeed, bIL-8-luc DNA may
have transfected several lung cell types, leading to the signal
amplification orchestrated by the complex cellular network of the
lung parenchyma. Although this is an important issue to be
explored, it is out of the scope of the present study.
Noteworthy, bIL-8-luc transiently transgenized mice could be
stimulated with LPS or TNF-a up to 60 days. Thus, the
capability to monitor a biological process longitudinally in the
same mouse represents an obvious advance for functional as well
as pharmacological studies. The correlation between WBC and
neutrophils infiltration and luciferase expression following LPS or
TNF-a stimulation is in accordance with the recognized IL-8 role
Figure 2. bIL-8-Luc reporter construct response in vivo.A ) Representative images of groups of mice (n=3 per group) transiently transgenized
with bIL-8-Luc or Empty vector DNA and intratracheally instilled with LPS, TNF-a or vehicle (saline solution). Mice were monitored at 3, 5 and 24 hours
post stimulation by BLI drawing a region of interest (ROI) over the chest. B) Light intensity quantification of the ROI using the LivingImage software.
The experiment was repeated three times and each point represents the mean 6 standard deviation of 9 animals. C) Data were expressed as folds of
induction over vehicle-treated mice (Saline) and statistical differences were tested by One Way ANOVA followed by Dunnet’s post hoc test for group
comparisons. Results are reported as mean 6 SD and significance attributed when P,0.05 (*) or P,0.01(**).
doi:10.1371/journal.pone.0039716.g002
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validating the association between IL-8 transcriptional activation
and pulmonary inflammation in the experimental setting that we
here adopted. Although a bovine promoter was used in this study
as a proof of concept, the results of the study suggest that IL-8
promoter regions derived from other species, including primates,
could also be utilized in this experimental setting.
IL-8 exerts a wide variety of actions on pulmonary disease
pathophysiology in ruminants and human during bacterial or
viral infection, acute respiratory distress syndrome (ARDS),
reperfusion injury and transplantation, lung injuries due to
physical and chemical conditions, allergic inflammation and
asthma, idiopathic pulmonary fibrosis and other diffuse lung
diseases, including lung cancer [2,4]. The absence of IL-8 and its
receptor orthologs in small rodents hindered the possibility of
testing novel strategies targeting IL-8 using mice as a convenient
small size experimental animal model. We filled the gap by
generating a mouse model transiently expressing a reporter gene
under the control of an IL-8 promoter which is suitable to




bIL-8-Luc was obtained by sub-cloning the 2030 bp IL8 bovine
promoter, amplified by PCR from Madin-Darby bovine kidney
(MDBK; ATCC #CCL-22) genomic DNA and subcloned into the
digested pGL3basic vector (Promega) as previously described [17].
Whereas STAT-1-Luc and ELK-1-Luc containing the minimal
promoter of STAT-1 and ELK-1 human gene were obtained from
Switchgear Genomics.
Cell Cultures
Mouse lung adenocarcinoma cell line of epithelial origin, LA-4
cells (ATTC, #CCL-196), was cultured in Dulbecco’s modified
essential medium (Sigma) containing 10% FBS, 2 mM of L-
glutamine, 100 IU/ml of penicillin, 100 mg/ml of streptomycin,
and 2.5 mg/ml of amphotericin B (Sigma). Cell culture plates or
flasks were incubated at 37uC with 5% CO2 in air, in a humidified
atmosphere.
LA-4 Cells Characterization by RT-PCR for TNF-aRI and II
and TLRs
Total RNA from LA-4 cells was extracted with TriPure reagent
(Roche) and 5 mg of total RNA were reverse transcribed using
Figure 3. Long lasting response of bIL-8-Luc reporter construct. A) Representative images of groups of mice (n=3 per group) transiently
transgenized with bIL-8-Luc or Empty vector DNA and intratracheally instilled with LPS, TNF-a or vehicle (saline solution) at 8, 32, 45 and 60 days post
transgenization. Mice were monitored at 3 hours post stimulation by BLI by drawing a region of interest (ROI) over the chest. B) Light intensity
quantification of the ROI using the LivingImage software. The experiment was repeated three times and each point represents the mean 6 standard
deviation of 9 animals. C) Data were expressed as folds of induction over vehicle-treated mice (Saline) and statistical differences were tested by One
Way ANOVA followed by Dunnet’s post hoc test for group comparisons. Results are reported as mean 6 SD and significance attributed when P,0.05
(*) or P,0.01(**).
doi:10.1371/journal.pone.0039716.g003
Figure 4. White blood cells and neutrophils infiltration. Cellular infiltration into the lung of mice intratracheally instilled with LPS, TNF-a or
vehicle. The amount of White blood cells (WBC), Neutrophils (Neut) and Monocytes (Mono) found in BALF was expressed as number of cells per mla t
3 (A) and 24 hours (B) post treatment. The experiment was repeated three times and each point represents the mean 6 standard deviation of 9
animals. Data were expressed as folds of induction over vehicle-treated mice (Saline) and statistical differences were tested by One Way ANOVA
followed by Dunnet’s post hoc test for group comparisons. Results are reported as mean 6 SD and significance attributed when P,0.05 (*) or
P,0.01(**).
doi:10.1371/journal.pone.0039716.g004
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es). Two microliters of the resulting cDNA were amplified in a
final volume of 50 ml of 10 mM Tris–hydrochloride, pH 8.3,
containing 0.2 mM deoxynucleotide triphosphates, 2.5 mM
MgCl2, 50 mM KCl, 1 U of Taq polymerase (Invitrogen) and
0.25 mM of each primer listed in Table S1. The amplification
program for TNF-aRI, II and GAPDH was 35 cycles, each cycle
consisting of denaturation at 94uC for 1 min, primer annealing at
55uC for 1 min, and chain elongation at 72uC for 1 min [33]. The
amplification program for TLRs was 35 cycles, each cycle
consisting of denaturation at 94uC for 1 min, primer annealing
at 55uC for 1 min, and chain elongation at 72uC for 1 min [34].
PCR products were analyzed on a 2% agarose gel.
LA-4 Cell Electroporation
LA-4 cells were cultured in a 75 cm
2 flask. When growth
reached 90% confluence cells were electroporated. bIL-8-Luc
plasmid DNA (20 mg) diluted in 600 ml of DMEM without serum
was electroporated (Equibio apparatus Wolf Laboratories Limit.,
York, UK) into LA-4 cells at 186 V, 960 mF, in 4-mm gap cuvettes
(Wolf Laboratories Limit., York, UK)). Electroporated cells were
plated in a twenty four-well plates and incubated in an atmosphere
of 95% air and 5% CO2 at 37uC.
Dual Luciferase Reporter Assay
Twenty-four hours post electroporation, LA-4 cells in twenty
four-well plates were treated with LPS (500 ng/ml) (Sigma) or
TNF-a (10 ng/ml) (Sigma) for four hours.
The luciferase reporter assay was performed with a Dual
Luciferase Reporter Assay System kit (Promega Corp., Madison,
WI, USA) according to the manufacturer’s specification with
minor modifications. Following treatment, cells were washed with
PBS and lysed with 100 ml of passive lysis buffer by freeze-thawing
at 280uC. Ten microliters of the cell lysate were added to 50 mlo f
LAR and Luciferase activity was determined with a PerkinElmer
Victor
3 Multilabel Counter (PerkinElmer, Waltham, MA, USA),
according to the manufacturer’s specifications. Experiments were
performed with 4 replicates at each time point and each
experiment repeated three times. Statistical differences were tested
by One Way ANOVA followed by Dunnet’s post hoc test for
group comparisons.
Experimental Animals
Female inbred FVB (7–8 week-old) mice were purchased from
Harlan Laboratories Italy (San Pietro al Natisone, Udine). Animals
were maintained under conventional housing conditions. Prior to
use, animals were acclimatized for at least 5 days to the local
vivarium conditions (room temperature: 20–24uC; relative hu-
midity: 40–70%), having free access to standard rat chow and tap
water. All experiments were carried out in rodents and exclusively
included painless suppression of animals. The experiments comply
with the Principles of Animal Care (publication no. 85–23, revised
1985) of the National Institutes of Health and with the current law
of the European Union and Italy (D. L.vo 116/92). The present
project was approved by the Ethical Committee of the University
of Parma (Italy).
In vivo Gene Delivery
We applied in vivo JetPEI (Polyplus Transfection) as a carrier for
delivering DNA to lung tissues. The DNA and JetPEI mix was
formulated according to the product manual with a final N/P ratio
of 7. Briefly, 40 mg of bIL-8–luc, STAT-1-Luc, ELK-1-Luc or
pGL3 basic reporters and 7 mL of JetPEI were each diluted into
200 mL 5% glucose. The two solutions were then mixed and
incubated for 15 minutes at room temperature. The entire mixture
was i.v. injected into FVB mice and the expression of bIL-8–Luc,
STAT-1-Luc, ELK-1-Luc or pGL3 basic reporters was monitored
through imaging with IVIS.
In vivo Bioluminescence Imaging (BLI)
In vivo imaging was performed using an IVIS imaging system
(Caliper Life Sciences, Alameda, CA). From 10 days after DNA
delivery the transient transgenic mice were imaged in order to
check the baseline activation of the IL-8 pathway. The day after
transgenization, the mice were intratracheally challenged with
LPS (12.5 mg/mouse) or TNF-a (1 mg/mouse) and the lungs
imaged using bioluminescence (BLI) after 2, 4, 7 and 24 hours
following intraperitoneal injection of 150 mg/kg luciferin. The
mice were anesthetized with gas anaesthesia (isoflurane 2.5%),
imaged for 5 minutes, 10 minutes and 15 minutes after luciferin
injection in order to minimized the pharmacokinetic variability
among mice. Photons emitted from specific regions were
quantified using Living ImageH software (Caliper Life Sciences,
Alameda, CA).
Bronchoalveolar Lavage Fluid (BALF) and Cell Counting
Bronchoalveolar lavage (BAL) was performed as previously
described [35]. Briefly, mouse tracheas were cannulated with an
18-gauge angiocathether (Becton Dickinson). Six hundred micro-
liters of sterile HANK’S buffer were instilled three times in the
bronchial tree and collected for subsequent analysis. After
centrifugation at 400 g for 10 minutes, the cell pellet was
resuspended in 0.2 ml of PBS. Total cell number was counted
with a particle counter (Dasit XT 1800J). The pellets deriving from
the same animal were combined and resuspended in a volume of
0.2 ml and total and differential cell counts were performed within
2 hours using an automated cell counter (Dasit xt 1800 J, Sysmex).
The cell count per animal was calculated from the number of cells
for 1 ml of BALF multiplied for the volume used for the re-
suspension of the cell pellet.
Statistics
Experiments were performed with 4 replicates at each time
point and each experiment repeated three times. Data were
analysed using One Way ANOVA followed by Dunnet’s post hoc
test for group comparisons. Results are reported as mean 6 SD
and significance attributed when P,0.05 (*) or P,0.01(**).
Supporting Information
Figure S1 Representative images of groups of mice
(n=3 per group) transiently transgenized with ELK-1-
Luc or STAT-1-Luc DNA and intratracheally instilled
with LPS or TNF-a. Mice were monitored at 3, 5 and 24 hours
post stimulation by BLI and no signal was detectable.
(TIF)
Table S1 List of primers used in this work.
(DOC)
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